# X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma

> **NCT04389281** · PHASE1 · RECRUITING · sponsor: **Immunolight, LLC** · enrollment: 52 (estimated)

## Conditions studied

- Advanced Solid Tumor Cancer

## Interventions

- **COMBINATION_PRODUCT:** X-PACT

## Key facts

- **NCT ID:** NCT04389281
- **Lead sponsor:** Immunolight, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-08
- **Primary completion:** 2028-09
- **Final completion:** 2029-03
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04389281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04389281, "X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04389281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*